Loading insider details...
Beta
Latest Form 4 (Aug 3, 2026): Grant/Award of 18,000 KLRS shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 3, 2026 | Kalaris Therapeutics, Inc. (KLRS) | Grant/Award | 18,000 | n/a |
| Jun 22, 2026 | PepGen Inc. (PEPG) | Grant/Award | 34,000 | n/a |
| Jun 11, 2026 | Immuneering Corp (IMRX) | Grant/Award | 33,350 | n/a |
| Jan 2, 2026 | Immuneering Corp (IMRX) | Grant/Award | 7,888 | n/a |
| Jun 16, 2025 | Immuneering Corp (IMRX) | Grant/Award | 33,350 | n/a |
| Jun 6, 2025 | PepGen Inc. (PEPG) | Grant/Award | 16,000 | n/a |
| Jan 2, 2025 | Immuneering Corp (IMRX) | Grant/Award | 23,485 | n/a |
| Jun 21, 2024 | PepGen Inc. (PEPG) | Grant/Award | 13,000 | n/a |
| Jun 13, 2024 | Immuneering Corp (IMRX) | Grant/Award | 33,350 | n/a |
| Jan 2, 2024 | Immuneering Corp (IMRX) | Grant/Award | 6,879 | n/a |